Status:
WITHDRAWN
Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis
Lead Sponsor:
Temple University
Conditions:
Venous Thrombosis
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
PHASE2
Brief Summary
99mTc-rBitistatin is a radiolabeled polypeptide which is designed to stick to blood clots so that the blood clots can be detected by imaging. The purpose of this trial is to evaluate in patients the s...
Eligibility Criteria
Inclusion
- peripheral acute venous thrombosis diagnosed by vascular ultrasound
- is able to give informed consent
- is likely to complete the study
Exclusion
- is pregnant
- is lactating
- has a history of prior severe allergic reactions (anaphylactic response)
- prior use of GP IIb/IIIa antagonist (e.g., abciximab, eptifibatide)
- has a platelet count \<100,000 or history of thrombocytopenia
- has a history of stroke
- has a history of recent bleeding documented by decreasing hemoglobin (\>1 gm) in last 7 days
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00808626
Start Date
December 1 2008
End Date
March 1 2017
Last Update
May 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Temple University Hospital
Philadelphia, Pennsylvania, United States, 19140